Goddard Glenn

CIK 00015819922 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001581992

Recent Transactions

50 trades

Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-03-01+41,316→ 41,316 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-01+28,628→ 69,213 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$29.46/sh−5,365→ 40,585 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2024-01-01−3,062→ 3,064 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-01+3,062→ 45,950 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+27,484→ 42,888 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-03-01+38,834→ 38,834 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-04$37.21/sh−2,427→ 15,404 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2023-01-01−3,062→ 6,126 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-01+3,062→ 17,831 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+12,720→ 12,720 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-03-01+12,720→ 14,769 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+18,600→ 18,600 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2022-01-01−3,062→ 9,188 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01+3,062→ 3,062 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01$112.24/sh−1,013→ 2,049 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-07$14.58/sh+3,482→ 3,482 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-09-07−3,482→ 12,451 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-07$180.12/sh−3,482→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-31$14.58/sh+1,817→ 24,800 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-31$160.22/sh−24,800→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-31$19.27/sh+22,983→ 22,983 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-31−1,817→ 15,933 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-31−22,983→ 41,817 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$153.22/sh−704→ 4,496 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$19.27/sh+5,200→ 5,200 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−5,200→ 64,800 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$157.33/sh−496→ 900 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$155.29/sh−1,700→ 1,696 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$156.10/sh−300→ 1,396 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$154.29/sh−1,100→ 3,396 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-05−20,000→ 70,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-05$151.41/sh−9,568→ 530 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-05$19.27/sh+20,000→ 20,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-05$150.65/sh−9,902→ 10,098 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-05$152.13/sh−530→ 0 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-03-03+73,500→ 73,500 total
Award
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2021-03-03+12,250→ 12,250 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2020-03-02+125,000→ 125,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2018-12-18+17,750→ 17,750 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2018-11-01+90,000→ 90,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2018-11-01+90,000→ 90,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2016-02-16+20,330→ 108,572 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2015-09-24$88.89/sh−4,856→ 5,144 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2015-09-24+10,000→ 10,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2015-09-24$85.97/sh−6,000→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2015-09-24$23.10/sh+856→ 6,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2015-09-24−10,000→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2015-09-24−856→ 88,242 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2015-07-23−1,319→ 94,779 total

Companies

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR

CAMBRIDGE, MA, 02139

View on SEC.gov